EI 2040-9601 G | diphtheria toxoid Purified antigen: inactivated diphtheria toxin |
IgG | 0.01/0.1/1/2 IU/ml | 96 x 01 | |
EI 2050-9601 A | Bordetella pertussis toxin Purified antigen: highly purified Bordetella pertussis toxin |
IgA | 2/10/25/50 IU/ml | 96 x 01 | |
EI 2050-9601 G | Bordetella pertussis toxin Purified antigen: highly purified Bordetella pertussis toxin |
IgG | 5-200 IU/ml | 96 x 01 | |
EI 2050-9601 M | Bordetella pertussis incl. IgG/RF absorbent Purified antigen: inactivated Bordetella pertussis lysate |
IgM | semi-quantitative | 96 x 01 | |
EI 2050-9601-3 A | Bordetella FHA Purified antigen: highly purified Bordetella pertussis filamentous haemagglutinin |
IgA | 2-50 IU/ml | 96 x 01 | |
EI 2050-9601-3 G | Bordetella FHA Purified antigen: highly purified Bordetella pertussis filamentous haemagglutinin |
IgG | 5-200 IU/ml | 96 x 01 | |
EI 2050-9601-4 G | Bordetella pertactin Purified antigen: native Bordetella pertussis pertactin |
IgG | 5/25/50/100 IU/ml | 96 x 01 | |
EI 2060-9601 G | tetanus toxoid Purified antigen: inactivated tetanus toxin |
IgG | 0,01/0,1/1/2/5 IU/ml | 96 x 01 | |
EI 2080-9601 A | Helicobacter pylori Purified antigen: bacterial lysate, strain “ATCC 43504″ |
IgA | semi-quantitative | 96 x 01 | |
EI 2080-9601 G | Helicobacter pylori Purified antigen: bacterial lysate, strain “ATCC 43504″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2081-9601 A | Helicobacter pylori (CagA) Purified antigen: recombinant CagA, expression in E. coli |
IgA | semi-quantitative | 96 x 01 | |
EI 2081-9601 G | Helicobacter pylori (CagA) Purified antigen: recombinant CagA, expression in E. coli |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2091-9601 A | Campylobacter jejuni Purified antigen: detergent extract, strain “ATCC 33291″ |
IgA | semi-quantitative | 96 x 01 | |
EI 2091-9601 G | Campylobacter jejuni Purified antigen: detergent extract, strain “ATCC 33291″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2111-9601 G | Treponema pallidum Purified antigen: 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2111-9601 M | Treponema pallidum incl. IgG/RF absorbent Purified antigen: 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
IgM | semi-quantitative | 96 x 01 | |
EI 2111-9601 O | Treponema pallidum Screen ELISA Purified antigen: 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
IgGM | 2/20/200 RU/ml | 96 x 01 | |
EI 2111-0208-8 L G | CSQ pair of controls anti-Treponema pallidum (IgG) |
IgG | 02 x 08 | ||
EI 2111-9601-L G | Treponema pallidum antibody determination in CSF Purified antigen: 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
IgG | 5/25/50/100 U | 96 x 01 | |
EI 2132-9601 M | Borrelia incl. IgG/RF absorbent Purified antigen: whole antigen, detergent extracts of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii |
IgM | 2/20/200 RU/ml | 96 x 01 | |
EI 2132-9601-1 G | Borrelia burgdorferi VlsE Purified antigen: recombinant VlsE from Borrelia burgdorferi sensu stricto |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2132-9601-2 G | Borrelia plus VlsE Purified antigen: whole antigen, detergent extracts of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii plus recombinant VlsE from Borrelia burgdorferi sensu stricto |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2132-9601-5 G | Borrelia Select Purified antigen: mixture of specific recombinant Borrelia antigens incl. VlsE |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2132-9601-5 M | Borrelia Select Purified antigen: mixture of specific recombinant Borrelia antigens |
IgM | 2/20/200 RU/ml | 96 x 01 | |
EI 2132-0208-8 L G | CSQ pair of controls anti-Borrelia (IgG) |
IgG | 02 x 08 | ||
EI 2132-0208-8 L M | CSQ pair of controls anti-Borrelia (IgM) |
IgM | 02 x 08 | ||
EI 2132-9601-L G | Borrelia PLUS VlsE antibody determination in CSF Purified antigen: whole antigen, detergent extracts of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii PLUS recombinant VlsE from Borrelia burgdorferi sensu stricto |
IgG | 5-230 U | 96 x 01 | |
EI 2132-9601-L M | Borrelia antibody determination in CSF Purified antigen: whole antigen, detergent extracts of Borrelia burgdorferi sensu stricto, Borrelia garinii and Borrelia afzelii |
IgM | 5/25/50/100/175 U | 96 x 01 | |
EI 2150-9601 A | Legionella pneumophila Purified antigen: native, lipopolysaccharide (LPS) of serotypes 1 – 7 |
IgA | semi-quantitative | 96 x 01 | |
EI 2150-9601 G | Legionella pneumophila Purified antigen: native, lipopolysaccharide (LPS) of serotypes 1 – 7 |
IgG | <14c6/td> | 2/20/200 RU/ml | 96 x 01 |
EI 2150-9601 M | Legionella pneumophila incl. IgG/RF absorbent Purified antigen: native, lipopolysaccharide (LPS) of serotypes 1 – 7 |
IgM | semi-quantitative | 96 x 01 | |
EI 2173-9601 A | Yersinia enterocolitica Detection of antibodies against virulence factors of the Yersinia enterocolitica pathogen in human serum (for diagnosing various forms of arthritis) Purified antigen: recombinant Yop D of Yersinia enterocolitica |
IgA | semi-quantitative | 96 x 01 | |
EI 2173-9601 G | Yersinia enterocolitica Detection of antibodies against virulence factors of the Yersinia enterocolitica pathogen in human serum (for diagnosing various forms of arthritis) Purified antigen: isolated virulence factors (release proteins, Yop) of Yersinia enterocolitica |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2189-9601 A | Brucella abortus Purified antigen: bacterial lysate, Brucella abortus strain “W99″ |
IgA | semi-quantitative | 96 x 01 | |
EI 2189-9601 G | Brucella abortus Purified antigen: bacterial lysate, Brucella abortus strain “W99″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2189-9601 M | Brucella abortus incl. IgG/RF absorbent Purified antigen: bacterial lysate, Brucella abortus strain “W99″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2190-9601 A | Chlamydia (C. pneumoniae/trachomatis Pool) Purified antigen: C. trach.: purified native MOMP antigen, serotype K C. pneum.: purified native antigens, strain “CWL-029″ |
IgA | semi-quantitative | 96 x 01 | |
EI 2190-9601 G | Chlamydia (C. pneumoniae/trachomatis Pool) Purified antigen: C. trach.: purified native MOMP antigen, serotype K C. pneum.: purified native antigens, strain “CWL-029″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2190-9601 M | Chlamydia (C. pneumoniae/trachomatis Pool) incl. IgG/RF absorbent Purified antigen: C. trach.: purified native MOMP antigen, serotype K C. pneum.: purified native antigens, strain “CWL-029″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2191-9601 A | Chlamydia trachomatis Purified antigen: purified native MOMP antigen, serotype K |
IgA | semi-quantitative | 96 x 01 | |
EI 2191-9601 G | Chlamydia trachomatis Purified antigen: purified native MOMP antigen, serotype K |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2191-9601 M | Chlamydia trachomatis incl. IgG/RF absorbent Purified antigen: purified native MOMP antigen, serotype K |
IgM | semi-quantitative | 96 x 01 | |
EI 2192-9601 A | Chlamydia pneumoniae Purified antigen: purified native antigens, strain “CWL-029″ |
IgA | semi-quantitative | 96 x 01 | |
EI 2192-9601 G | Chlamydia pneumoniae Purified antigen: purified native antigens, strain “CWL-029″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2192-9601 M | Chlamydia pneumoniae incl. IgG/RF absorbent Purified antigen: purified native antigens, strain “CWL-029″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2202-9601 A | Mycoplasma pneumoniae Purified antigen: detergent extract of strain “Mac ATCC 15531″ |
IgA | semi-quantitative | 96 x 01 | |
EI 2202-9601 G | Mycoplasma pneumoniae Purified antigen: detergent extract of strain “Mac ATCC 15531″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2202-9601 M | Mycoplasma pneumoniae incl. IgG/RF absorbent Purified antigen: detergent extract of strain “Mac ATCC 15531″ |
EI 2410-9601 A | Toxoplasma gondii Purified antigen: purified antigens of Toxoplasma gondii |
IgA | semi-quantitative | 96 x 01 | |
EI 2410-9601 G | Toxoplasma gondii Purified antigen: purified antigens of Toxoplasma gondii |
IgG | 1/10/200 IU/ml | 96 x 01 | |
EI 2410-9601 M | Toxoplasma gondii incl. IgG/RF absorbent Purified antigen: purified antigens of Toxoplasma gondii |
IgM | semi-quantitative | 96 x 01 | |
EI 2410-9601 P | Toxoplasma gondii Screen Purified antigen: purified antigens of Toxoplasma gondii |
IgAGM | semi-quantitative | 96 x 01 | |
EI 2410-9601-1 G | Toxoplasma gondii avidity determination Purified antigen: purified antigens of Toxoplasma gondii |
IgG | 1/10/200 IU/ml | 96 x 01 | |
EI 2410-0208-8 L G | CSQ pair of controls anti-Toxoplasma gondii (IgG) |
IgG | 02 x 08 | ||
EI 2410-9601-L G | Toxoplasma gondii antibody determination in CSF Purified antigen: purified antigens of Toxoplasma gondii |
IgG | 5/25/50/100 U | 96 x 01 |
EI 2410-9601 A | Toxoplasma gondii Purified antigen: purified antigens of Toxoplasma gondii |
IgA | semi-quantitative | 96 x 01 | |
EI 2410-9601 G | Toxoplasma gondii Purified antigen: purified antigens of Toxoplasma gondii |
IgG | 1/10/200 IU/ml | 96 x 01 | |
EI 2410-9601 M | Toxoplasma gondii incl. IgG/RF absorbent Purified antigen: purified antigens of Toxoplasma gondii |
IgM | semi-quantitative | 96 x 01 | |
EI 2410-9601 P | Toxoplasma gondii Screen Purified antigen: purified antigens of Toxoplasma gondii |
IgAGM | semi-quantitative | 96 x 01 | |
EI 2410-9601-1 G | Toxoplasma gondii avidity determination Purified antigen: purified antigens of Toxoplasma gondii |
IgG | 1/10/200 IU/ml | 96 x 01 | |
EI 2410-0208-8 L G | CSQ pair of controls anti-Toxoplasma gondii (IgG) |
IgG | 02 x 08 | ||
EI 2410-9601-L G | Toxoplasma gondii antibody determination in CSF Purified antigen: purified antigens of Toxoplasma gondii |
IgG | 5/25/50/100 U | 96 x 01 |
EI 2525-9601 A | Hepatitis E virus (HEV) Purified antigen: recombinant target antigens from Hepatits E virus genotypes 1 and 3 |
IgA | semi-quantitative | 96 x 01 | |
EI 2525-9601 G | Hepatitis E virus (HEV) Purified antigen: recombinant target antigens from Hepatits E virus genotypes 1 and 3 |
IgG | 0,2/2/10/25 IU/ml | 96 x 01 | |
EI 2525-9601 M | Hepatitis E virus (HEV) Purified antigen: recombinant target antigens from Hepatits E virus genotypes 1 and 3 |
IgM | semi-quantitative | 96 x 01 | |
EI 2525-9601 P | Hepatitis E virus (HEV) Purified antigen: recombinant target antigens from Hepatits E virus genotypes 1 and 3 |
IgAGM | semi-quantitative | 96 x 01 | |
EI 2531-9601-1 A | Herpes simplex virus (HSV-1/2 Pool) Purified antigen: HSV-1: strain “Mac Intyre” (ATCC VR-539) HSV-2: strain “MS” (ATCC VR-540) |
IgA | semi-quantitative | 96 x 01 | |
EI 2531-9601-1 G | Herpes simplex virus (HSV-1/2 Pool) Purified antigen: HSV-1: strain “Mac Intyre” (ATCC VR-539) HSV-2: strain “MS” (ATCC VR-540) |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2531-9601-1 L G | Herpes simplex virus (HSV-1/2 Pool) antibody determination in CSF Purified antigen: HSV-1: strain “Mac Intyre” (ATCC VR-539) HSV-2: strain “MS” (ATCC VR-540) |
IgG | 5-230 U/ml | 96 x 01 | |
EI 2531-9601-1 M | Herpes simplex virus (HSV-1/2 Pool) incl. IgG/RF absorbent Purified antigen: HSV-1: strain “Mac Intyre” (ATCC VR-539) HSV-2: strain “MS” (ATCC VR-540) |
IgM | semi-quantitative | 96 x 01 | |
EI 2531-9601-2 G | Herpes simplex virus 1 (HSV-1) Purified antigen: glycoprotein C1 |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2531-9601-2 M | Herpes simplex virus 1 (HSV-1) incl. IgG/RF absorbent Purified antigen: glycoprotein C1 |
IgM | semi-quantitative | 96 x 01 | |
EI 2531-0208-8 L G | CSQ pair of controls anti-HSV-1/2 Pool (IgG) |
IgG | 02 x 08 | ||
EI 2531-9601-L G | Herpes simplex virus 1 (HSV-1) antibody determination in CSF Purified antigen: glycoprotein C1 |
IgG | 5/25/50/100 U | 96 x 01 | |
EI 2531-0208-10 L G | CSQ pair of controls anti-HSV-1 (IgG) |
IgG | 02 x 08 | ||
EI 2532-9601-2 G | Herpes simplex virus 2 (HSV-2) Purified antigen: glycoprotein G2 |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2532-9601-2 M | Herpes simplex virus 2 (HSV-2) incl. IgG/RF absorbent Purified antigen: glycoprotein G2 |
IgM | semi-quantitative | 96 x 01 | |
EI 2532-0208-8 L G | CSQ pair of controls anti-HSV-2 (IgG) |
IgG | 02 x 08 | ||
EI 2532-9601-L G | Herpes simplex virus 2 (HSV-2) antibody determination in CSF Purified antigen: glycoprotein G2 |
IgG | 5/25/50/100 U | 96 x 01 | |
EI 2570-9601 G | Cytomegalovirus (CMV) Purified antigen: purified native antigens, strain “AD169″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2570-9601 M | Cytomegalovirus (CMV) incl. IgG/RF absorbent Purified antigen: purified native antigens, strain “AD169″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2570-9601-1 G | Cytomegalovirus (CMV) avidity determination Purified antigen: purified native antigens, strain “AD169″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2570-0208-8 L G | CSQ pair of controls anti-Cytomegalovirus (IgG) |
IgG | 02 x 08 | ||
EI 2570-9601-L G | Cytomegalovirus (CMV) antibody determination in CSF Purified antigen: purified native antigens, strain “AD169″ |
IgG | 5/25/50/100 U | 96 x 01 | |
EI 2580-9601 G | Parvovirus B19 Purified antigen: recombinant viral structural protein expressed in eukaryotic cells |
IgG | 1/5/25/100 IU/ml | 96 x 01 | |
EI 2580-9601 M | Parvovirus B19 incl. IgG/RF absorbent Purified antigen: recombinant viral structural protein expressed in eukaryotic cells |
IgM | semi-quantitative | 96 x 01 | |
EI 2590-9601 G | Rubella virus Purified antigen: purified native antigens, strain “HPV-77″ |
IgG | 1/10/50/200 IU/ml | 96 x 01 | |
EI 2590-9601 M | Rubella virus incl. IgG/RF absorbent Purified antigen: purified native antigens, strain “HPV-77″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2590-9601-1 G | Rubella virus avidity determination Purified antigen: purified native antigens, strain “HPV-77″ |
IgG | 1/10/50/200 IU/ml | 96 x 01 | |
EI 2590-9601-2 M | Rubella virus glycoprotein incl. IgG/RF absorbent Purified antigen: native, purified glycoproteins, strain “HPV-77″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2590-0208-8 L G | CSQ pair of controls anti-Rubella virus (IgG) |
IgG | 02 x 08 | ||
EI 2590-9601-L G | Rubella virus antibody determination in CSF Purified antigen: purified native antigens, strain “HPV-77″ |
IgG | 5-230 U | 96 x 01 | |
EI 2610-9601 G | Measles virus Purified antigen: purified native antigens, strain “Edmonston” (ATCC VR-24) |
IgG | 50-5000 IU/l | 96 x 01 | |
EI 2610-9601 M | Measles virus incl. IgG/RF absorbent Purified antigen: purified native antigens, strain “Edmonston” (ATCC VR-24) |
IgM | semi-quantitative | 96 x 01 | |
EI 2610-9601-1 G | Measles virus avidity determination Purified antigen: purified native antigens, strain “Edmonston” (ATCC VR-24) |
IgG | 50-5000 IU/l | 96 x 01 | |
EI 2610-9601-4 M | Measles virus (NP) incl. IgG/RF absorbent Purified antigen: nucleoprotein from S. cerevisiae |
IgM | semi-quantitative | 96 x 01 | |
EI 2610-0208-8 L G | CSQ pair of controls anti-Measles virus (IgG) |
IgG | 02 x 08 | ||
EI 2610-9601-L G | Measles virus antibody determination in CSF Purified antigen: purified native antigens, strain “Edmonston” (ATCC VR-24) |
IgG | 5-230 U | 96 x 01 | |
EI 2630-9601 G | Mumps virus Purified antigen: purified native antigens, strain “Enders” (ATCC VR-106) |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2630-9601 M | Mumps virus incl. IgG/RF absorbent Purified antigen: purified native antigens, strain “Enders” (ATCC VR-106) |
IgM | semi-quantitative | 96 x 01 | |
EI 2630-9601-3 G | Mumps virus AT Purified antigen: purified native antigens, strains “Enders” (ATCC VR-106) and “Jeryl Lynn” |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2630-9601-5 M | Mumps virus G5 incl. IgG/RF absorbent Purified antigen: purified native antigens, genotype “G5″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2630-0208-8 L G | CSQ pair of controls anti-Mumps virus (IgG) |
IgG | 02 x 08 | ||
EI 2630-9601-L G | Mumps virus antibody determination in CSF Purified antigen: purified native antigens, strain “Enders” (ATCC VR-106) |
IgG | 5/25/50/100 U | 96 x 01 | |
EI 2650-9601 A | Varicella zoster virus (VZV) Purified antigen: purified native antigens, strain “Ellen” |
IgA | semi-quantitative | 96 x 01 | |
EI 2650-9601 G | Varicella zoster virus (VZV) Purified antigen: purified native antigens, strain “Ellen” |
IgG | 10/100/500/5000 IU/l | 96 x 01 | |
EI 2650-9601 M | Varicella zoster virus (VZV) incl. IgG/RF absorbent Purified antigen: purified native antigens, strain “VZ-10″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2650-9601-1 G | Varicella zoster virus (VZV) avidity determination Purified antigen: purified native antigens, strain “Ellen” |
IgG | 10/100/500/5000 IU/l | 96 x 01 | |
EI 2650-9601-2 M | Varicella zoster virus (VZV) glycoprotein incl. IgG/RF absorbent Purified antigen: purified native glycoproteins, strain “Ellen” |
IgM | semi-quantitative | 96 x 01 | |
EI 2650-0208-8 L G | CSQ pair of controls anti-VZV (IgG) |
IgG | 02 x 08 | ||
EI 2650-9601-L G | Varicella zoster virus (VZV) antibody determination in CSF Purified antigen: purified native antigens, strain “Ellen” |
IgG | 5-230 U | 96 x 01 | |
EI 2661-9601 G | TBE virus Purified antigen: highly purified TBE viral proteins (strain “K23″) |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2661-9601 M | TBE virus incl. IgG/RF absorbent Purified antigen: highly purified TBE viral proteins (strain “K23″) |
IgM | semi-quantitative | 96 x 01 | |
EI 2661-9601-1 G | TBE virus avidity determination Purified antigen: highly purified TBE viral proteins (strain “K23″) |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2661-0208-8 L M | CSQ pair of controls anti-TBE virus (IgM) |
IgM | 02 x 08 | ||
EI 2661-0208-8 L G | CSQ pair of controls anti-TBE virus (IgG) |
IgG | 02 x 08 | ||
EI 2661-9601-9 G | TBE virus Vienna Purified antigen: highly purified TBE viral proteins (strain “K23″) |
IgG | 15-1000 VIEU/ml | 96 x 01 | |
EI 2661-9601-L G | TBE virus antibody determination in CSF Purified antigen: highly purified TBE viral proteins (strain “K23″) |
IgG | 5/25/50/100 U | 96 x 01 | |
EI 2661-9601-L M | TBE virus antibody determination in CSF Purified antigen: highly purified TBE viral proteins (strain “K23″) |
IgM | 5/25/50/100 U | 96 x 01 | |
EI 2661-0208-10 L G | CSQ pair of controls anti-TBE virus Vienna (IgG) |
IgG | 02 x 08 | ||
EI 2662-9601 G | West Nile virus (WNV) Purified antigen: detergent-extracted glycoprotein E from the membrane fraction of human cells |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2662-9601 M | West Nile virus (WNV) incl. IgG/RF absorbent Purified antigen: detergent-extracted glycoprotein E from the membrane fraction of human cells |
IgM | semi-quantitative | 96 x 01 | |
EI 2662-9601-1 G | West Nile virus (WNV) avidity determination Purified antigen: detergent-extracted glycoprotein E from the membrane fraction of human cells |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2663-9601 G * | Japanese encephalitis virus (JEV) Purified antigen: detergent-extracted glycoprotein E from the membrane fraction of human cells |
IgG | 2/20/200 RU/ml | 96 x 01 | |
2000EI 2663-9601 M * | Japanese encephalitis virus (JEV) Purified antigen: detergent-extracted glycoprotein E from the membrane fraction of human cells |
IgM | semi-quantitative | 96 x 01 | |
EI 2667-9601 G | Usutu virus Purified antigen: purified glycoprotein E of Usutu virus |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 266b-9601 A | Dengue virus (DENV) Purified antigen: highly purified preparation of Dengue virus particles (type 2) |
IgA | semi-quantitative | 96 x 01 | |
EI 266b-9601 G | Dengue virus (DENV) Purified antigen: highly purified preparation of Dengue virus particles (type 2) |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 266b-9601 M | Dengue virus (DENV) incl. IgG/RF absorbent Purified antigen: highly purified preparation of Dengue virus particles (type 2) |
IgM | semi-quantitative | 96 x 01 | |
EI 2670-9601 A | Respiratory syncytial virus (RSV) Purified antigen: purified native antigens, strain “Long” |
IgA | semi-quantitative | 96 x 01 | |
EI 2670-9601 G | Respiratory syncytial virus (RSV) Purified antigen: purified native antigens, strain “Long” |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2670-9601 M | Respiratory syncytial virus (RSV) incl. IgG/RF absorbent Purified antigen: purified native antigens, strain “Long” |
IgM | semi-quantitative | 96 x 01 | |
EI 2680-9601 A | Adenovirus Purified antigen: purified native antigens, strain “Adenoid 6″ |
IgA | semi-quantitative | 96 x 01 | |
EI 2680-9601 G | Adenovirus Purified antigen: purified native antigens, strain “Adenoid 6″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2680-9601 M | Adenovirus incl. IgG/RF absorbent Purified antigen: purified native antigens, strain “Adenoid 6″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2691-9601 A | Influenza virus type A Purified antigen: strains “Texas” (H3N2), “California” (H1N1) and “Singapore” (H1N1) |
IgA | semi-quantitative | 96 x 01 | |
EI 2691-9601 G | Influenza virus type A Purified antigen: strains “Texas” (H3N2), “California” (H1N1) and “Singapore” (H1N1) |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2691-9601 M | Influenza virus type A incl. IgG/RF absorbent Purified antigen: strains “Texas” (H3N2), “California” (H1N1) and “Singapore” (H1N1) |
IgM | semi-quantitative | 96 x 01 | |
EI 2691-9601-1 A | Influenza virus types A and B (Pool) Purified antigen: see individual ELISA |
IgA | semi-quantitative | 96 x 01 | |
EI 2691-9601-1 G | Influenza virus types A and B (Pool) Purified antigen: see individual ELISA |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2691-9601-1 M | Influenza virus types A and B (Pool) Purified antigen: see individual ELISA |
IgM | semi-quantitative | 96 x 01 | |
EI 2692-9601 A | Influenza virus type B Purified antigen: strain “Hong Kong 5/72″ |
IgA | semi-quantitative | 96 x 01 | |
EI 2692-9601 G | Influenza virus type B Purified antigen: strain “Hong Kong 5/72″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2692-9601 M | Influenza virus type B incl. IgG/RF absorbent Purified antigen: strain “Hong Kong 5/72″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2721-9601-1 A | Parainfluenza virus types 1 – 4 (Pool) Purified antigen: purified native antigens, strains “VP1″, “Greer”, “C-234″ and “M25″ |
IgA | semi-quantitative | 96 x 01 | |
EI 2721-9601-1 G | Parainfluenza virus types 1 – 4 (Pool) Purified antigen: purified native antigens, strains “VP1″, “Greer”, “C-234″ and “M25″ |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2721-9601-1 M | Parainfluenza virus types 1 – 4 (Pool) incl. IgG/RF absorbent Purified antigen: purified native antigens, strains “VP1″, “Greer”, “C-234″ and “M25″ |
IgM | semi-quantitative | 96 x 01 | |
EI 2730-9601-1 A | Enterovirus Purified antigen: purified VP1 of ECHO 6 / Coxsackie B5 virus |
IgA | semi-quantitative | 96 x 01 | |
EI 2730-9601-1 G | Enterovirus Purified antigen: purified VP1 of ECHO 6 / Coxsackie B5 virus |
IgG | semi-quantitative | 96 x 01 | |
EI 2730-9601-1 M | Enterovirus incl. IgG/RF absorbent Purified antigen: purified VP1 of ECHO 6 / Coxsackie B5 virus |
IgM | semi-quantitative | 96 x 01 | |
EI 278h-9601-1 G | Hantavirus Pool 1 “Eurasia” Purified antigen: purified recombinant nucleocapsid proteins from strains Hantaan HTNV Fojnica, Dobrava DOBV Slovenia, Puumala PUUV Vranica |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 278h-9601-1 M | Hantavirus Pool 1 “Eurasia” incl. IgG/RF absorbent Purified antigen: purified recombinant nucleocapsid proteins from strains Hantaan HTNV Fojnica, Dobrava DOBV Slovenia, Puumala PUUV Vranica |
IgM | semi-quantitative | 96 x 01 | |
EI 278h-9601-2 G | Hantavirus Pool 2 “America” Purified antigen: purified recombinant nucleocapsid proteins from strains Andes ANDV and Sin Nombre SNV |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 278h-9601-2 M | Hantavirus Pool 2 “America” incl. IgG/RF absorbent Purified antigen: purified recombinant nucleocapsid proteins from strains Andes ANDV and Sin Nombre SNV |
IgM | semi-quantitative | 96 x 01 | |
EI 2791-9601 A | Epstein-Barr virus capsid antigen (EBV-CA) Purified antigen: native, mixture of several viral capsid antigens |
IgA | b5d | semi-quantitative | 96 x 01 |
EI 2791-9601 G | Epstein-Barr virus capsid antigen (EBV-CA) Purified antigen: native, mixture of several viral capsid antigens |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2791-9601 M | Epstein-Barr virus capsid antigen (EBV-CA) incl. IgG/RF absorbent Purified antigen: native, gp125 of EBV infected P3HR1 cells |
IgM | semi-quantitative | 96 x 01 | |
EI 2791-9601-1 G | Epstein-Barr virus capsid antigen (EBV-CA) avidity determination Purified antigen: native, mixture of several viral capsid antigens |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2791-0208-8 L G | CSQ pair of controls anti-EBV-CA (IgG) |
IgG | 02 x 08 | ||
EI 2791-9601-L G | Epstein-Barr virus capsid antigen (EBV-CA) antibody determination in CSF Purified antigen: native, mixture of several viral capsid antigens |
IgG | 5/25/50/100 U | 96 x 01 | |
EI 2793-9601 G | Epstein-Barr virus nuclear antigen (EBNA-1) Purified antigen: recombinant, expression in insect cells |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2795-9601 A | Epstein-Barr virus early antigen (EBV-EA) Purified antigen: recombinant, EBV-EA-D (diffuse), expression in E. coli |
IgA | semi-quantitative | 96 x 01 | |
EI 2795-9601 G | Epstein-Barr virus early antigen (EBV-EA) Purified antigen: recombinant, EBV-EA-D (diffuse), expression in E. coli |
IgG | 2/20/200 RU/ml | 96 x 01 | |
EI 2795-9601 M | Epstein-Barr virus early antigen (EBV-EA) incl. IgG/RF absorbent Purified antigen: recombinant, EBV-EA-D (diffuse), expression in E. coli |
IgM | semi-quantitative | 96 x 01 | |
EI 293a-9601 G | Chikungunya virus (CHIKV) Purified antigen: recombinant structural protein from Chikungunya virus |
IgG | 2/20/200 RU/ml | 96 x 01 |
Recenzije
Još nema recenzija.